Home

LUKE M BESHAR

CIK 1192128 · EVP & CFO · last filed 2026-06-16

LUKE M BESHAR is an EVP & CFO who has filed 67 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for TARA, was dated Jun 16, 2026. Across all open-market trades the lifetime net is −$17.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $929.6K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$929.6K

Companies

5

Total Filings

67

Lifetime Open-Market Net

-$17.22M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TARA Director 198,000 $3.98 $788.0K $118.1K 12 2026-06-16
Omega Therapeutics, Inc. (OMGA) Delisted Director — $0.14 — $0 3 2023-06-09
RGNX Director 12,784 $11.07 $141.5K -$4.18M 11 2021-06-08
NPS PHARMACEUTICALS INC (NPSP) Delisted EVP & CFO 0 — — -$12.66M 34 2015-02-24
CAMBREX CORP (CBM) Delisted Executive Vice President 0 — — -$497.0K 6 2007-10-12

Recent Filings

67 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-16 TARA Grant (A) — $0 EDGAR
2025-06-13 TARA Grant (A) — $0 EDGAR
2024-06-10 TARA Grant (A) — $0 EDGAR
2023-06-09 Omega Therapeutics, Inc. (OMGA) Delisted Grant (A) — $0 EDGAR
2023-06-08 TARA Grant (A) — $0 EDGAR
2022-07-05 TARA Buy (P) +10,000 $31.0K EDGAR
2022-06-10 Omega Therapeutics, Inc. (OMGA) Delisted Grant (A) — $0 EDGAR
2022-06-09 TARA Grant (A) — $0 EDGAR
2022-03-16 TARA Buy (P) +10,000 $42.5K EDGAR
2022-03-14 TARA Buy (P) +10,000 $44.6K EDGAR
Showing 1–10 of 67
Page 1 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.